186 related articles for article (PubMed ID: 21740409)
1. The 5-HT3B subunit affects high-potency inhibition of 5-HT3 receptors by morphine.
Baptista-Hon DT; Deeb TZ; Othman NA; Sharp D; Hales TG
Br J Pharmacol; 2012 Feb; 165(3):693-704. PubMed ID: 21740409
[TBL] [Abstract][Full Text] [Related]
2. Exploring a potential palonosetron allosteric binding site in the 5-HT(3) receptor.
Del Cadia M; De Rienzo F; Weston DA; Thompson AJ; Menziani MC; Lummis SC
Bioorg Med Chem; 2013 Dec; 21(23):7523-8. PubMed ID: 24128813
[TBL] [Abstract][Full Text] [Related]
3. Direct subunit-dependent multimodal 5-hydroxytryptamine3 receptor antagonism by methadone.
Deeb TZ; Sharp D; Hales TG
Mol Pharmacol; 2009 Apr; 75(4):908-17. PubMed ID: 19131665
[TBL] [Abstract][Full Text] [Related]
4. Subunit-dependent inhibition and potentiation of 5-HT3 receptor by the anticancer drug, topotecan.
Nakamura Y; Ishida Y; Yamada T; Kondo M; Shimada S
J Neurochem; 2013 Apr; 125(1):7-15. PubMed ID: 23305320
[TBL] [Abstract][Full Text] [Related]
5. RIC-3 exclusively enhances the surface expression of human homomeric 5-hydroxytryptamine type 3A (5-HT3A) receptors despite direct interactions with 5-HT3A, -C, -D, and -E subunits.
Walstab J; Hammer C; Lasitschka F; Möller D; Connolly CN; Rappold G; Brüss M; Bönisch H; Niesler B
J Biol Chem; 2010 Aug; 285(35):26956-26965. PubMed ID: 20522555
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological differences and similarities between the native mouse 5-HT3 receptor in N1E-115 cells and a cloned short splice variant of the mouse 5-HT3 receptor expressed in HEK 293 cells.
Brüss M; Molderings GJ; Bönisch H; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep; 360(3):225-33. PubMed ID: 10543422
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological and electrophysiological properties of the naturally occurring Pro391Arg variant of the human 5-HT3A receptor.
Kurzwelly D; Barann M; Kostanian A; Combrink S; Bönisch H; Göthert M; Brüss M
Pharmacogenetics; 2004 Mar; 14(3):165-72. PubMed ID: 15167704
[TBL] [Abstract][Full Text] [Related]
8. Influence of sodium substitutes on 5-HT-mediated effects at mouse 5-HT3 receptors.
Barann M; Schmidt K; Göthert M; Urban BW; Bönisch H
Br J Pharmacol; 2004 Jun; 142(3):501-8. PubMed ID: 15148263
[TBL] [Abstract][Full Text] [Related]
9. Agonists and antagonists bind to an A-A interface in the heteromeric 5-HT3AB receptor.
Lochner M; Lummis SC
Biophys J; 2010 Apr; 98(8):1494-502. PubMed ID: 20409468
[TBL] [Abstract][Full Text] [Related]
10. Menthol inhibits 5-HT3 receptor-mediated currents.
Ashoor A; Nordman JC; Veltri D; Yang KH; Shuba Y; Al Kury L; Sadek B; Howarth FC; Shehu A; Kabbani N; Oz M
J Pharmacol Exp Ther; 2013 Nov; 347(2):398-409. PubMed ID: 23965380
[TBL] [Abstract][Full Text] [Related]
11. The nonpsychoactive cannabinoid cannabidiol inhibits 5-hydroxytryptamine3A receptor-mediated currents in Xenopus laevis oocytes.
Yang KH; Galadari S; Isaev D; Petroianu G; Shippenberg TS; Oz M
J Pharmacol Exp Ther; 2010 May; 333(2):547-54. PubMed ID: 20160007
[TBL] [Abstract][Full Text] [Related]
12. Agonist- and antagonist-induced up-regulation of surface 5-HT3 A receptors.
Morton RA; Baptista-Hon DT; Hales TG; Lovinger DM
Br J Pharmacol; 2015 Aug; 172(16):4066-77. PubMed ID: 25989383
[TBL] [Abstract][Full Text] [Related]
13. Importance of recognition loops B and D in the activation of human 5-HT₃ receptors by 5-HT and meta-chlorophenylbiguanide.
Michaelson SD; Paulsen IM; Kozuska JL; Martin IL; Dunn SM
Neuropharmacology; 2013 Oct; 73():398-403. PubMed ID: 23810831
[TBL] [Abstract][Full Text] [Related]
14. Competitive and non-competitive effects of 5-hydroxyindole on 5-HT3 receptors in N1E-115 neuroblastoma cells.
Kooyman AR; van Hooft JA; Vanderheijden PM; Vijverberg HP
Br J Pharmacol; 1994 Jun; 112(2):541-6. PubMed ID: 8075873
[TBL] [Abstract][Full Text] [Related]
15. Natural compounds boldine and menthol are antagonists of human 5-HT3 receptors: implications for treating gastrointestinal disorders.
Walstab J; Wohlfarth C; Hovius R; Schmitteckert S; Röth R; Lasitschka F; Wink M; Bönisch H; Niesler B
Neurogastroenterol Motil; 2014 Jun; 26(6):810-20. PubMed ID: 24708203
[TBL] [Abstract][Full Text] [Related]
16. 5-HT3 Receptor Brain-Type B-Subunits are Differentially Expressed in Heterologous Systems.
Corradi J; Thompson AJ; McGonigle I; Price KL; Bouzat C; Lummis SC
ACS Chem Neurosci; 2015 Jul; 6(7):1158-64. PubMed ID: 25951416
[TBL] [Abstract][Full Text] [Related]
17. The identification of N-glycosylated residues of the human 5-HT3B receptor subunit: importance for cell membrane expression.
Massoura AN; Dover TJ; Newman AS; Barnes NM
J Neurochem; 2011 Mar; 116(6):975-83. PubMed ID: 21138434
[TBL] [Abstract][Full Text] [Related]
18. Introduction of the 5-HT3B subunit alters the functional properties of 5-HT3 receptors native to neuroblastoma cells.
Stewart A; Davies PA; Kirkness EF; Safa P; Hales TG
Neuropharmacology; 2003 Feb; 44(2):214-23. PubMed ID: 12623220
[TBL] [Abstract][Full Text] [Related]
19. Ginger and its pungent constituents non-competitively inhibit activation of human recombinant and native 5-HT3 receptors of enteric neurons.
Walstab J; Krüger D; Stark T; Hofmann T; Demir IE; Ceyhan GO; Feistel B; Schemann M; Niesler B
Neurogastroenterol Motil; 2013 May; 25(5):439-47, e302. PubMed ID: 23490018
[TBL] [Abstract][Full Text] [Related]
20. The 5-HT3B subunit is a major determinant of serotonin-receptor function.
Davies PA; Pistis M; Hanna MC; Peters JA; Lambert JJ; Hales TG; Kirkness EF
Nature; 1999 Jan; 397(6717):359-63. PubMed ID: 9950429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
